文献速递炎症性肠病

HIV感染与炎症性肠病较轻表型相关:ENEIDA登记处多中心研究

HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.
PubMed 文献 · Am J Gastroenterol · 2024-07-15

该病例对照、回顾性研究纳入ENEIDA登记处364例患者(91例HIV阳性IBD和273例HIV阴性IBD对照,按诊断年份、年龄、性别和IBD类型1:3匹配),发现HIV-IBD组溃疡性结肠炎中直肠炎比例和克罗恩病中结肠定位比例显著更高、肠外表现更少,非生物制剂和生物制剂使用更少,但机会性感染更多。多因素分析显示HIV感染(OR 4.765,95%CI 2.48-9.14;P<0.001)和≥1种合并症(OR 2.445,95%CI 1.23-4.85;P=0.010)是机会性感染的危险因素,而克罗恩病具有保护作用(OR 0.372,95%CI 0.18-0.78;P=0.009)。

要点

  • HIV-IBD组溃疡性结肠炎中直肠炎比例更高,克罗恩病中结肠定位比例更高,肠外表现更少。
  • HIV-IBD组非生物制剂(37.4% vs 57.9%;P=0.001)和生物制剂(26.4% vs 42.1%;P=0.007)使用均少于对照。
  • HIV感染(OR 4.765,95%CI 2.48-9.14;P<0.001)和≥1种合并症(OR 2.445,95%CI 1.23-4.85;P=0.010)是机会性感染危险因素,克罗恩病有保护作用(OR 0.372,95%CI 0.18-0.78;P=0.009)。

核心结论

  • HIV感染似乎与炎症性肠病较轻表型相关,非生物制剂和生物制剂使用较少,但机会性感染风险更高。

研究设计与样本

  • 病例对照、回顾性研究,纳入ENEIDA登记处所有HIV阳性且诊断为IBD的患者,与HIV血清阴性对照按诊断年份、年龄、性别和IBD类型1:3匹配。
  • 共纳入364例患者,其中HIV-IBD组91例,IBD对照组273例。
  • 全队列中58%为溃疡性结肠炎,35%为克罗恩病,7%为未分类IBD。

主要发现

  • HIV-IBD组溃疡性结肠炎中直肠炎比例显著高于对照,克罗恩病中结肠定位比例显著高于对照,肠外表现少于对照。
  • HIV-IBD组非生物制剂使用率为37.4%,对照组为57.9%(P=0.001);生物制剂使用率为26.4%,对照组为42.1%(P=0.007)。
  • HIV-IBD组机会性感染多于对照,无论是否使用非生物制剂。
  • 多因素分析中,HIV感染(OR 4.765,95%CI 2.48-9.14;P<0.001)和≥1种合并症(OR 2.445,95%CI 1.23-4.85;P=0.010)是机会性感染的危险因素,克罗恩病具有保护作用(OR 0.372,95%CI 0.18-0.78;P=0.009)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The coexistence of HIV infection and inflammatory bowel disease (IBD) is uncommon. Data on the impact of HIV on IBD course and its management are scarce. The aim of this study was to describe the IBD phenotype, therapeutic requirements, and prevalence of opportunistic infections (OIs) in IBD patients with a coexistent HIV infection. METHODS: Case-control, retrospective study includes all HIV-positive patients diagnosed with IBD in the Nationwide study on genetic and environmental determinants of inflammatory bowel disease registry. Patients with positive HIV serology (HIV-IBD) were compared with controls (HIV seronegative), matched 1:3 by year of IBD diagnosis, age, sex, and type of IBD. RESULTS: A total of 364 patients (91 HIV-IBD and 273 IBD controls) were included. In the whole cohort, 58% had ulcerative colitis, 35% had Crohn's disease (CD), and 7% were IBD unclassified. The HIV-IBD group presented a significantly higher proportion of proctitis in ulcerative colitis and colonic location in CD but fewer extraintestinal manifestations than controls. Regarding treatments, nonbiological therapies (37.4% vs 57.9%; P = 0.001) and biologicals (26.4% vs 42.1%; P = 0.007), were used less frequently among patients in the HIV-IBD group. Conversely, patients with HIV-IBD developed more OI than controls, regardless of nonbiological therapy use. In the multivariate analysis, HIV infection (odds ratio 4.765, 95% confidence interval (CI) 2.48-9.14; P < 0.001) and having ≥1 comorbidity (OR 2.445, 95% CI 1.23-4.85; P = 0.010) were risk factors for developing OI, while CD was protective (OR 0.372, 95% CI 0.18-0.78; P = 0.009). DISCUSSION: HIV infection seems to be associated with a less aggressive phenotype of IBD and a lesser use of nonbiological therapies and biologicals but entails a greater risk of developing OI.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Calafat M, Suria C, Mesonero F, et al. HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry. Am J Gastroenterol. 2024. PMID: 39888687. doi:10.14309/ajg.0000000000002965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。